how to not lose muscle on semaglutide and Tirzepatide Affect Mass SHEDDING FAT, NOT MUSCLE: COMBATING
Description
Wanting is believed to originate within the dopaminergic mesolimbic pathway, projecting from the ventral tegmental area (VTA) to the nucleus accumbens (NAcc), whereas liking arises from discrete hedonic hotspots in the brain, independent of dopamine release
Han et al., 2018a
Clinical trial data on the active ingredients in both semaglutide and tirzepatide show significant weight loss in adults with obesity or overweight
(Awwad Alenezy), M.H.H., S.H., S.M., N.F.A., A.A
Effects of GLP-1 and Amylin Agonists on Hypothalamic Appetite Regulation
